Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABAA/benzodiazepine receptor complex and GABA content
Identifieur interne : 001627 ( Istex/Curation ); précédent : 001626; suivant : 001628Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABAA/benzodiazepine receptor complex and GABA content
Auteurs : Frédéric Calon ; Marc Morissette ; Martin Goulet ; Richard Grondin ; Pierre J. Blanchet ; Paul J. Bédard ; Thérèse Di Paolo [Canada]Source :
- Neurochemistry International [ 0197-0186 ] ; 1999.
Abstract
The effect of various chronic dopaminergic treatments in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) monkeys on the brain γ-aminobutyric acid type A (GABAA) /benzodiazepine receptor complex and GABA content was investigated in order to assess the GABAergic involvement in dopaminomimetic-induced dyskinesia. Three MPTP monkeys received for one month pulsatile administrations of the D1 dopamine (DA) receptor agonist SKF 82958 whereas three others received the same dose of SKF 82958 by continuous infusion. A long acting D2 DA receptor agonist, cabergoline, was given to another three animals. Untreated MPTP as well as naive control animals were also included. Pulsatile SKF 82958 relieved parkinsonian symptoms but was also associated with dyskinesia in two of the three animals whereas animals treated continuously with SKF 82958 remained as untreated MPTP monkeys. Chronic cabergoline administration improved motor response with no persistent dyskinesia. MPTP treatment induced a decrease of 3H-flunitrazepam binding in the medial anterior part of caudate-putamen and an increase in the internal segment of globus pallidus (GPi) which was in general unchanged by pulsatile or continuous SKF 82958 administration. Throughout the striatum, binding of 3H-flunitrazepam remained reduced in MPTP monkeys treated with cabergoline but was not significantly lower than untreated MPTP monkeys. Moreover, cabergoline treatment reversed the MPTP-induced increase in 3H-flunitrazepam binding in the GPi. GABA concentrations remained unchanged in the striatum, external segment of globus pallidus and GPi following MPTP denervation. Pulsatile but not continuous SKF 82958 administration decreased putamen GABA content whereas cabergoline treatment decreased caudate GABA. No alteration in GABA levels were observed in the GPe and GPi following the experimental treatments. These results suggest that: (1) D2-like receptor stimulation with cabergoline modulates GABAA receptor density in striatal subregions anatomically related to associative cortical afferent and (2) the absence of dyskinesia in dopaminomimetic-treated monkeys might be associated with the reversal of the MPTP-induced upregulation of the GABAA/benzodiazepine receptor complex in the Gpi.
Url:
DOI: 10.1016/S0197-0186(99)00064-9
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001627
Links to Exploration step
ISTEX:E53B627CD5410880AC565F2E90E0D394A66D7DCDCuration
No country items
Frédéric Calon<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>Unité de Recherche en Neuroscience, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>Unité de Recherche en Neuroscience, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABAA/benzodiazepine receptor complex and GABA content</title>
<author><name sortKey="Calon, Frederic" sort="Calon, Frederic" uniqKey="Calon F" first="Frédéric" last="Calon">Frédéric Calon</name>
<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Morissette, Marc" sort="Morissette, Marc" uniqKey="Morissette M" first="Marc" last="Morissette">Marc Morissette</name>
<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Goulet, Martin" sort="Goulet, Martin" uniqKey="Goulet M" first="Martin" last="Goulet">Martin Goulet</name>
<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Grondin, Richard" sort="Grondin, Richard" uniqKey="Grondin R" first="Richard" last="Grondin">Richard Grondin</name>
<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Blanchet, Pierre J" sort="Blanchet, Pierre J" uniqKey="Blanchet P" first="Pierre J" last="Blanchet">Pierre J. Blanchet</name>
<affiliation><mods:affiliation>Unité de Recherche en Neuroscience, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bedard, Paul J" sort="Bedard, Paul J" uniqKey="Bedard P" first="Paul J" last="Bédard">Paul J. Bédard</name>
<affiliation><mods:affiliation>Unité de Recherche en Neuroscience, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Thérèse" last="Di Paolo">Thérèse Di Paolo</name>
<affiliation wicri:level="1"><mods:affiliation>E-mail: therese.dipaolo@crchul.ulaval.ca</mods:affiliation>
<country wicri:rule="url">Canada</country>
</affiliation>
<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E53B627CD5410880AC565F2E90E0D394A66D7DCD</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1016/S0197-0186(99)00064-9</idno>
<idno type="url">https://api-v5.istex.fr/document/E53B627CD5410880AC565F2E90E0D394A66D7DCD/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001627</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001627</idno>
<idno type="wicri:Area/Istex/Curation">001627</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABAA/benzodiazepine receptor complex and GABA content</title>
<author><name sortKey="Calon, Frederic" sort="Calon, Frederic" uniqKey="Calon F" first="Frédéric" last="Calon">Frédéric Calon</name>
<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Morissette, Marc" sort="Morissette, Marc" uniqKey="Morissette M" first="Marc" last="Morissette">Marc Morissette</name>
<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Goulet, Martin" sort="Goulet, Martin" uniqKey="Goulet M" first="Martin" last="Goulet">Martin Goulet</name>
<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Grondin, Richard" sort="Grondin, Richard" uniqKey="Grondin R" first="Richard" last="Grondin">Richard Grondin</name>
<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Blanchet, Pierre J" sort="Blanchet, Pierre J" uniqKey="Blanchet P" first="Pierre J" last="Blanchet">Pierre J. Blanchet</name>
<affiliation><mods:affiliation>Unité de Recherche en Neuroscience, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bedard, Paul J" sort="Bedard, Paul J" uniqKey="Bedard P" first="Paul J" last="Bédard">Paul J. Bédard</name>
<affiliation><mods:affiliation>Unité de Recherche en Neuroscience, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
<wicri:noCountry code="subField">4G2</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Thérèse" last="Di Paolo">Thérèse Di Paolo</name>
<affiliation wicri:level="1"><mods:affiliation>E-mail: therese.dipaolo@crchul.ulaval.ca</mods:affiliation>
<country wicri:rule="url">Canada</country>
</affiliation>
<affiliation><mods:affiliation>Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Québec, Canada, G1V 4G2</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Neurochemistry International</title>
<title level="j" type="abbrev">NCI</title>
<idno type="ISSN">0197-0186</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1999">1999</date>
<biblScope unit="volume">35</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="81">81</biblScope>
<biblScope unit="page" to="91">91</biblScope>
</imprint>
<idno type="ISSN">0197-0186</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0197-0186</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The effect of various chronic dopaminergic treatments in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) monkeys on the brain γ-aminobutyric acid type A (GABAA) /benzodiazepine receptor complex and GABA content was investigated in order to assess the GABAergic involvement in dopaminomimetic-induced dyskinesia. Three MPTP monkeys received for one month pulsatile administrations of the D1 dopamine (DA) receptor agonist SKF 82958 whereas three others received the same dose of SKF 82958 by continuous infusion. A long acting D2 DA receptor agonist, cabergoline, was given to another three animals. Untreated MPTP as well as naive control animals were also included. Pulsatile SKF 82958 relieved parkinsonian symptoms but was also associated with dyskinesia in two of the three animals whereas animals treated continuously with SKF 82958 remained as untreated MPTP monkeys. Chronic cabergoline administration improved motor response with no persistent dyskinesia. MPTP treatment induced a decrease of 3H-flunitrazepam binding in the medial anterior part of caudate-putamen and an increase in the internal segment of globus pallidus (GPi) which was in general unchanged by pulsatile or continuous SKF 82958 administration. Throughout the striatum, binding of 3H-flunitrazepam remained reduced in MPTP monkeys treated with cabergoline but was not significantly lower than untreated MPTP monkeys. Moreover, cabergoline treatment reversed the MPTP-induced increase in 3H-flunitrazepam binding in the GPi. GABA concentrations remained unchanged in the striatum, external segment of globus pallidus and GPi following MPTP denervation. Pulsatile but not continuous SKF 82958 administration decreased putamen GABA content whereas cabergoline treatment decreased caudate GABA. No alteration in GABA levels were observed in the GPe and GPi following the experimental treatments. These results suggest that: (1) D2-like receptor stimulation with cabergoline modulates GABAA receptor density in striatal subregions anatomically related to associative cortical afferent and (2) the absence of dyskinesia in dopaminomimetic-treated monkeys might be associated with the reversal of the MPTP-induced upregulation of the GABAA/benzodiazepine receptor complex in the Gpi.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001627 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001627 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:E53B627CD5410880AC565F2E90E0D394A66D7DCD |texte= Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABAA/benzodiazepine receptor complex and GABA content }}
This area was generated with Dilib version V0.6.29. |